Home Antibody All anti-F13A1 antibodies
Also for F13A1 (NM_000129)
|Recombinant fragment corresponding to a region within amino acids 1 and 258 of Factor XIIIa (Uniprot ID#P00488)|
|Human (Predicted: Mouse, Rat, Bovine)
||Lot dependent; please refer to CoA along with shipment
|WB, IHC, IF
||ICC/IF:1:100-1:1000; IHC:1:100-1:1000; WB:1:500-1:3000
|0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.|
|Purified by antigen-affinity chromatography.
|Seq homology of immunogen across species: Mouse (86%), Rat (84%), Bovine (86%)
|Homo sapiens coagulation factor XIII A chain (F13A1)|
Entrez Gene 2162 Human
Entrez Gene 74145 Mouse
Entrez Gene 60327 Rat
|This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq]|
|Secreted ProteinDruggable Genome Complement and coagulation cascades|
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Sample (30 ug of whole cell lysate). A:H1299. 7.5 % SDS PAGE. TA308878 diluted at 1:1000
Immunohistochemical analysis of paraffin-embedded H520 xenograft, using Factor XIIIa(TA308878) antibody at 1:500 dilution.
Immunofluorescence analysis of paraformaldehyde-fixed A549, using Factor XIIIa(TA308878) antibody at 1:200 dilution.